ArticleBirth defects research2026
Congenital Anomaly Prevalence: A 10-Year Retrospective Study in a Tertiary Hospital in Turkey.
Article in Birth defects research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCongenital anomalies (CA) are health problems that can significantly affect individuals, families, health systems, and society. Our aim is to present the characteristics of CA observed in babies born at our institution between 2014 and 2023, including the Covid-19 pandemic period. MATERIALS AND
methodsRetrospective data obtained from the delivery room records and hospital information system of Pamukkale University Hospital were analyzed.
resultsDuring the 10-year period covered by our study at our institution, 16,030 births occurred, and 941 (5.87%) newborns were diagnosed with CA. The most common anomalies were cardiovascular system (CVS) (42%), other congenital malformations (5%), musculoskeletal system (4%), and central nervous system (CNS) anomalies (7%). Two hundred twenty-nine newborns (24%) were found to have multiple congenital anomalies. The prevalence of CA was higher in 2020, 2021, and 2022 (during the COVID-19 pandemic) compared to other years. The mortality rate among newborns with CA was 21.25%. Of the CA babies who died, 37.5% had CVS, 30% had multiple anomalies, and 9% had CNS anomalies. The mortality rate due to congenital anomalies, based on the total number of births in our hospital, was 1.25%.
conclusionWe found that the mortality rate among newborns with CA was 21.25% and that the incidence of anomalies increased during the COVID-19 pandemic. Multidisciplinary efforts are required to provide parents with the necessary information during pregnancy and the prepregnancy planning period. It is crucial to examine the prevalence of CA during the Covid-19 pandemic period in other regional studies and to evaluate the impact of such epidemics on anomalies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.